Searched for
WHO GMP
Utkal Speciality Industries IPO: Check GMP, price band, subscription and other detailsUtkal Speciality Industries India's IPO opens Wednesday, aiming to raise Rs 34.5 crore with shares priced between Rs 62-66. The SME issue, ...- CMR Green Technologies IPO allotment today: Check status online as GMP signals 34% listing premiumCMR Green IPO Allotment Status: CMR Green Technologies IPO investors are set to receive allotment updates on June 8 after the Rs 631 crore ...
- Over 60% of pharma MSMEs yet to comply with updated manufacturing normsPharma industry officials say the revised Schedule M regulations could require Rs 10-15 crore per facility in upgrades, while talent shorta...
- Did you get OnEMI Technology IPO allotment? The GMP ahead of listing is the best in last few monthsInvestors can check their OnEMI Technology IPO allotment status today. The fintech company's public issue closed on May 5. Shares are set t...
- Lord’s Mark among few global players to win HIV self-test approval, exports from June 2026Lord's Mark Industries Ltd. has secured Central Licensing Authority approval for its LordsMed HIV 1&2 Self Test, becoming one of nine globa...
- Drug regulator oversight sought for nutraceuticals; NGO flags quality, pricing concernsA Gujarat NGO is pushing the government to regulate nutraceuticals like medicines. They cite concerns about product quality and unregulated...
- Sai Parenteral’s IPO allotment likely today: Check status, GMP, other detailsSai Parenteral's IPO share allotment is expected today, with investors able to check their status on BSE or the registrar's website. The is...
- Powerica IPO allotment likely today: Check status, GMP, other detailsPowerica's IPO share allotment is likely to be finalized today. Investors can check their status on BSE or the registrar's website. The com...
- IPO Calendar: No fresh issues next week; Coal India subsidiary, 6 more companies set to debutThe primary market anticipates a quiet week with no new IPOs. Focus shifts to the listing of Coal India's subsidiary, CMPDI, on Monday. Six...
- CMPDI IPO allotment: Did you receive Coal India subsidiary's shares? Check status, GMP, issue timelineCentral Mine Planning & Design Institute Ltd (CMPDI) IPO share allotment is expected today. The Rs 1,842 crore Offer for Sale (OFS) saw ful...
- Pharma companies must adopt revised quality norms: Government“The idea is to bring in quality and reduce manufacturing of those drugs which are not of standard quality. A need has been felt to revisit...
- DCGI initiates review of pharma manufacturing standards to ensure drug quality and safetyIndia's drug regulator, the Drug Controller General of India (DCGI), plans to review pharmaceutical manufacturing standards in order to ens...
- Emami to expand ayurvedic product export under ZanduEmami plans to export its healthcare portfolio under Zandu into several newer markets with the company receiving the WHO-GMP and Certificat...
- Ratan Tata invests in Generic Aadhaar to bring affordable medicines to massesGeneric Aadhaar follows a pharmacy-aggregator business model sourcing generic drugs directly from the manufacturer and providing it to the ...
- Lasa Supergenerics jumps 5% on Maha FDA nodThe drug will be manufactured at its WHO GMP certified facility at Mahad Industrial Area.
- Soon, interest subsidy on loans for pharmaceutical infrastructure, technology upgradesThe Department of Pharmaceuticals proposes to bear 6% of the interest on loans up to Rs 8-10 crore for three years, through a public sector...
- Government taking steps to set up funds to promote pharma sectorThe government is taking a number of initiatives to help pharma firms upgrade technology and promote drug discovery and innovation in the c...
- Hester Biosciences reports 35% growth in 2012-13The company on Thursday said its turnover increased to Rs 651.04 mn over 482.64 mn recorded in 2011-12.
- Domestic drug makers will not need GMP certificateDomestic drug makers will no longer need a certificate of good manufacturing practice (GMP) from WHO to sell their medicines within India.
- GMPs may take toll on drug exportsIn what could hit the country’s vaccine exports estimated to be at Rs 1,500 crore, besides maligning the reputation of Indian companies, WH...
Load More
